fisher & paykel mr850 respiratory humidifier device
al mashriq medical supplies llc new zealand - 1 device unit - device - device - medical devices-medical devices
endoform antimicrobial dermal template combination dressing
l m m drug store llc new zealand - 10’s [10 pouches of 5x5cm] 629312 - dressing - combination - medical devices-medical devices
endoform natural dermal template combination dressing
l m m drug store llc new zealand - 10’s [10 pouches of disc] 529315 - dressing - combination - medical devices-medical devices
myriad combination implant
l m m drug store llc new zealand - 1’s [1 pouch of 5x5 cm] sr05lg0505us - implant - combination - medical devices-medical devices
endoform antimicrobial restorative bioscaffold combination dressing
al reef drug store new zealand - 10’s [10 pouches of 5x5cm] 629312 - dressing - combination - medical devices-medical devices
endoform natural restorative bioscaffold combination dressing
al reef drug store new zealand - 10’s [10 pouches of disc] 529315 - dressing - combination - medical devices-medical devices
myriad matrix soft tissue bioscaffold combination implant
al reef drug store new zealand - 1’s [1 pouch of 7x10 cm] sr05lg0710us - implant - combination - medical devices-medical devices
newcastle-bronchitis vaccine, bl type, lasota strain, mass type, live virus lyophilisate for solution for injection
newcastle bronchitis virus b1 type lasota strain and infectious bronchitis virus mass type - lyophilisate for solution for injection - each dose contains: newcastle-bronchitis virus b1 type lasota strain 106.0 eid50 and infectious bronchitis virus mass type 103.8 eid50 at the release. each dose contains: newcastle-bronchitis virus b1 type lasota strain 105.5 eid50 and infectious br
myriad morcells™ morcellized bioscaffold combination powder
al reef drug store new zealand - 1’s [1x500mg blister] pw01na0500 - powder - combination - medical devices-medical devices
erwinase
new zealand medical & scientific ltd - asparaginase 10000 [iu] - powder for injection - 10000 iu - active: asparaginase 10000 [iu] excipient: glucose monohydrate sodium chloride water for injection - erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. it may also be used in other neoplastic conditions where depletion of asparagines might be expected to have a useful effect. patients receiving treatment with l-asparaginase from escherichia coli, and who develop hypersensitivity to that enzyme may be able to continue treatment with erwinase as the enzymes are immunologically distinct.